Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Cash & Equivalents (2019 - 2024)

Historic Cash & Equivalents for Cresco Labs (CRLBF) over the last 5 years, with Q2 2024 value amounting to $112.3 million.

  • Cresco Labs' Cash & Equivalents changed N/A to $112.3 million in Q2 2024 from the same period last year, while for Jun 2024 it was $112.3 million, marking a year-over-year change of. This contributed to the annual value of $103.4 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Cresco Labs reported Cash & Equivalents of $112.3 million as of Q2 2024.
  • Cresco Labs' Cash & Equivalents' 5-year high stood at $131.0 million during Q2 2021, with a 5-year trough of $57.7 million in Q3 2020.
  • Moreover, its 4-year median value for Cash & Equivalents was $103.4 million (2023), whereas its average is $94.5 million.